Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension

OBJECTIVE--To determine whether epoprostenol (prostacyclin, PGI2) or heart-lung transplantation (HLT), or both improves survival of patients with severe pulmonary hypertension. DESIGN--This was a prospective study where the effects of epoprostenol were compared with conventional treatment. Also, the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British Heart Journal Jg. 70; H. 4; S. 366 - 370
Hauptverfasser:	Higenbottam, T W, Spiegelhalter, D, Scott, J P, Fuster, V, Dinh-Xuan, A T, Caine, N, Wallwork, J
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London BMJ Publishing Group Ltd and British Cardiovascular Society 01.10.1993 BMJ BMJ Publishing Group LTD
Schlagworte:	Adult Biological and medical sciences Cardiovascular system Combined Modality Therapy Epoprostenol - therapeutic use Female Heart-Lung Transplantation Humans Hypertension, Pulmonary - drug therapy Hypertension, Pulmonary - mortality Hypertension, Pulmonary - surgery Hypertension, Pulmonary - therapy Male Medical sciences Pharmacology. Drug treatments Prospective Studies Survival Rate Vasodilator agents. Cerebral vasodilators Heart Human Vasodilator agent Prostaglandin I2 Respiratory disease Treatment efficiency Lung Cardiovascular disease Transplantation Homotransplantation Pulmonary hypertension Chemotherapy Treatment Surgery Comparative study
ISSN:	0007-0769, 1468-201X, 2053-5864
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!